GlucoVista Inc.
USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Glucovista ranks #35,524 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.
- #35,524
- of 49,997 US assignees by volume
- 23rd percentile
- by Innovation Score (27.2/100)
- 20.1
- avg claims per patent
- +33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R35524 · US Corporation #35,524 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #35,524/49,997
- PHOTO-FINISH Global Outdoors
- CPC-NARROW A61B · 5 areas
- INNOV-THIN 27.2/100
- CLAIMS-DENSE 20.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Global Outdoors, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Glucovista’s 27.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Glucovista
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- GlucoVista · this assignee 27
GlucoVista · this assignee
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Glucovista's Innovation Score is 27.2/100 (23rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Glucovista?
Each dot is one of Glucovista’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glucovista’s own 20.1 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Glucovista's grants concentrate
GlucoVista Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2019. By volume, Glucovista sits between Global Outdoors, Inc. and Go Natural CNG, LLC.
Who files at GlucoVista's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Global Outdoors
Global Outdoors, Inc.
7 patents
- Global Specimen S…
Global Specimen Solutions, Inc.
7 patents
- Global Water Grou…
Global Water Group, Incorporated
7 patents
- Globe Holding
Globe Holding Company LLC
7 patents
- Glue AB
Glue AB
7 patents
- Glux Visual Effec…
Glux Visual Effects Tech (Shenzhen) Co., Ltd
7 patents
- Gmax Biopharm
Gmax Biopharm LLC
7 patents
- Go Natural CNG
Go Natural CNG, LLC
7 patents
- Glucovista ◀
GlucoVista Inc.
7 patents
What this shows GlucoVista holds 7 patents at rank #35,551, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near GlucoVista
By rank, the assignees closest to #35,551 in granted patent volume.
- Global Outdoors, Inc. #35,547 · 7 patents
- Global Specimen Solutions, Inc. #35,548 · 7 patents
- Global Water Group, Incorporated #35,549 · 7 patents
- Globe Holding Company LLC #35,550 · 7 patents
- Glue AB #35,552 · 7 patents
- Glux Visual Effects Tech (Shenzhen) Co., Ltd #35,553 · 7 patents
- Gmax Biopharm LLC #35,554 · 7 patents
- Go Natural CNG, LLC #35,555 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in GlucoVista's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Glucovista's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 23rd percentile higher than 23% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 28.6% |
| 2019 | 1 | 14.3% |
| 2020 | 2 | 28.6% |
| 2021 | 2 | 28.6% |
Which technologies does GlucoVista Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
GlucoVista Inc.'s patent record in context - here's where to go next.
- GlucoVista Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #35,524 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare GlucoVista Inc. against Global Outdoors, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.